| Structure |
Chemical Name |
CAS |
MF |
 |
FMOC-21-AMINO-4,7,10,13,16,19-HEXAOXAHENEICOSANOIC ACID |
882847-34-9 |
C30H41NO10 |
 |
13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA |
27376-76-7 |
C20H34O5 |
 |
Posaconazole Impurity 16 |
213381-02-3 |
C37H42F2N8O4 |
 |
253128-14-2 |
253128-14-2 |
C70H130O13Si5 |
 |
4,7-DIMETHYLCOUMARIN |
14002-90-5 |
C11H10O2 |
 |
5-Fluoroindole |
399-52-0 |
C8H6FN |
 |
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide |
182182-31-6 |
C13H15FN2O2 |
 |
5-BRDU 5-bromo-2'-deoxyuridine |
|
|
 |
tetramethyl 3,3',3'',3'''-(porphyrin-5,10,15,20-tetrayl)tetrabenzoate |
75286-83-8 |
C52H38N4O8 |
 |
7-Chloro-1,2,3,4-tetrahydrobenzo(b)azepin-5-one |
160129-45-3 |
C10H10ClNO |
 |
4-methyl-7-nitro- 2H-chromen-2-one |
179897-88-2 |
C10H7NO4 |
 |
Cefradine double nucleus |
|
|
 |
Fulvestrant intermediate |
1610351-44-4 |
C30H46O6S |
 |
5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole |
97963-62-7 |
C8H6F2N2OS |
 |
ADENYLYL(3'>5')CYTIDINE FREE ACID |
2382-66-3 |
C19H25N8O11P |
 |
CEFMETAZOLE MMT ISOMER |
|
|
 |
Cyclobutanecarboxylic acid, 3-(methylamino)-, 1-methylethyl ester, cis- |
2136718-64-2 |
C9H17NO2 |
 |
Vanadyl Riboside Complex (RVC/VRC) |
|
|
 |
(9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate |
115057-37-9 |
C17H16N2O3 |
 |
Inosine API manufacturers |
|
|
 |
3’-deoxyinosine |
|
|
 |
Acetoxy Ceftazidime Intermediate |
|
|
 |
Flomoxef Intermediate FXMT |
|
|
 |
4-METHYL 6-HYDROXY 7-ACETOXY COUMARIN |
46895-13-0 |
C12H10O6 |
 |
Pyrazole |
288-13-1 |
C3H4N2 |
 |
9-OXO-11ALPHA,15S-DIHYDROXY-PROST-13E-EN-1-OIC-3,3,4,4-D4 ACID |
211105-33-8 |
C20H30D4O5 |
 |
7,10-Dioxa-2,5-diazaundecanoic acid, 4,9-dioxo-11-phenyl-, 9H-fluoren-9-ylmethyl ester |
1599440-07-9 |
C27H26N2O6 |
![2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN](/CAS/GIF/58336-35-9.gif) |
2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN |
58336-35-9 |
C15H15NO2 |
 |
3-Fluorobenzylamine |
100-82-3 |
C7H8FN |
 |
(3R,4R,5R)-Oseltamivir |
|
|
 |
4-Piperidinecarboxylic acid, 3-methyl-4-phenyl-, phenylmethyl ester, (3S,4R)- |
2357209-42-6 |
C20H23NO2 |
![(1R)-7-Chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione](/CAS/20211123/GIF/2300966-23-6.gif) |
(1R)-7-Chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione |
2300966-23-6 |
C16H14ClFN4O2 |
 |
(9H-fluoren-9-yl)methyl (R)-(3-(2-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
 |
6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline |
1936429-80-9 |
C10H10BrF2N |
![Spiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'-[1H]pyrido[3,4-b]indole]-14-carbonitrile, 5-(acetyloxy)-2',3',4',6,6a,7,9',13,14,16-decahydro-8-hydroxy-6',9-dimethoxy-4,10,23-trimethyl-19-oxo-, (1'R,6R,6aR,7R,13S,14R,16R)- (9CI)](/CAS/20211123/GIF/497871-10-0.gif) |
Spiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'-[1H]pyrido[3,4-b]indole]-14-carbonitrile, 5-(acetyloxy)-2',3',4',6,6a,7,9',13,14,16-decahydro-8-hydroxy-6',9-dimethoxy-4,10,23-trimethyl-19-oxo-, (1'R,6R,6aR,7R,13S,14R,16R)- (9CI) |
497871-10-0 |
C42H43N5O9S |
 |
2',3'-Didehydro-2',3'-dideoxy-5'-acetate inosine |
130676-57-2 |
C12H12N4O4 |
 |
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone |
101328-85-2 |
C11H13N3O |
 |
α-L-Idopyranoside, 4-methylphenyl 4,6-O-(1-methylethylidene)-3-O-(phenylmethyl)-1-thio- |
2234242-37-4 |
C23H28O5S |
 |
2-(2-pyridyl)isothiourea N-oxide hydrochloride |
2770-93-6 |
C6H8ClN3OS |
 |
disodium tetrabromophthalate |
25357-79-3 |
C8Br4Na2O4 |
 |
5-Pyrimidinecarboxylic acid, 2-chloro-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester |
1847463-39-1 |
C17H16ClN3O2 |
 |
cytidylyl(5'->3')adenosine |
4833-63-0 |
C19H25N8O11P |
 |
Aztreonam Dimer |
|
|
 |
(S)-2-Amino-5-methoxytetralin Hydrochloride |
58349-17-0 |
C11H15NO.HCl |
 |
2-Bromo-3',4'-(methylenedioxy)propiophenone |
52190-28-0 |
C10H9BrO3 |
 |
Ceftazidime Mother Nucleus Double-Bond Shift |
|
|
 |
3-(Hydroxymethyl)-1-adamantol |
38584-37-1 |
C11H18O2 |
 |
Hexanoic acid, 3-(aminomethyl)-5-methyl-, 2-methylpropyl ester, hydrochloride (1:1), (3S)- |
1239692-15-9 |
C12H26ClNO2 |
![4-Oxazolidinecarboxylic acid, 3-[(2S)-5-[[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopentyl]-2,2-dimethyl-, (4S)-](/CAS/20210305/GIF/2108145-17-9.gif) |
4-Oxazolidinecarboxylic acid, 3-[(2S)-5-[[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopentyl]-2,2-dimethyl-, (4S)- |
2108145-17-9 |
C40H49N5O9S |
 |
Cefminox for system suitability |
|
|
 |
Flomoxef Intermediate NaMT |
|
|
 |
3,4-(Methylenedioxy)aniline |
14268-66-7 |
C7H7NO2 |
 |
Methenolone enanthate |
303-42-4 |
C27H42O3 |
 |
8-OXO-DG |
|
|
 |
Methyl (R)-4,4-difluoropyrrolidine-2-carboxylate hydrochloride |
1408057-39-5 |
C6H10ClF2NO2 |
 |
9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID |
17968-82-0 |
C20H34O5 |
 |
2-Cyanoethyl 3-oxobutanoate |
65193-87-5 |
C7H9NO3 |
![Carbamic acid, N-[(14S,18S)-18,19,20,21-tetrahydro-25,25-dimethyl-15,22-dioxo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-, 1,1-dimethylethyl ester](/CAS/20240320/GIF/2764998-33-4.gif) |
Carbamic acid, N-[(14S,18S)-18,19,20,21-tetrahydro-25,25-dimethyl-15,22-dioxo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-, 1,1-dimethylethyl ester |
2764998-33-4 |
C35H48BN5O7S |
![5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-one hydrochloride](/CAS/GIF/115473-15-9.gif) |
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-one hydrochloride |
115473-15-9 |
C7H10ClNOS |
 |
Cefcanel |
41952-52-7 |
C19H18N4O5S3 |
 |
Eseroline |
469-22-7 |
C13H18N2O |
![(1S,2R,3S,5R)-2-(Benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol](/CAS/GIF/117641-39-1.gif) |
(1S,2R,3S,5R)-2-(Benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol |
117641-39-1 |
C13H16O3 |
 |
3,4-Diiodopyrazole |
6645-70-1 |
C3H2I2N2 |
![4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid](/CAS/GIF/641569-94-0.gif) |
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
641569-94-0 |
C17H14N4O2 |
 |
4-Methylphenylsulfonylurea |
1694-06-0 |
C8H10N2O3S |
 |
4-Bromopyrazole |
2075-45-8 |
C3H3BrN2 |
 |
Fmoc-GIn(Trt)-Aib-OH |
|
|
 |
tert-Butyl ((1r,4r)-4-((E)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)cyclohexyl)carbamate |
3057863-74-5 |
C19H34BNO4 |
 |
Fendizoic acid |
84627-04-3 |
C20H14O4 |
 |
Lysergamide, 1-acetyl-N,N-diethyl- (6CI,7CI) |
3270-02-8 |
C22H27N3O2 |
 |
4-(4-Chloro-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester |
5948-71-0 |
C14H15ClN2O3 |
 |
DIMETHYL-(3-(TRIFLUOROMETHYL)-PHENYL)-MALONATE |
138485-29-7 |
C12H11F3O4 |
![(6β)-3-(1-Methyl-1H-tetrazole-5-ylthiomethyl)-7α-amino-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid benzhydryl ester](/CAS/GIF/66510-99-4.gif) |
(6β)-3-(1-Methyl-1H-tetrazole-5-ylthiomethyl)-7α-amino-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid benzhydryl ester |
66510-99-4 |
C24H24N6O5S |
 |
tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate |
571188-59-5 |
C14H22N4O2 |
 |
N2-Isobutyryl-2'-Fluoro-2'-deoxyguanosine |
80681-25-0 |
C14H18FN5O5 |
 |
Ethyl 2-chloroethoxyl acetic acid |
17229-14-0 |
C6H11ClO3 |
![BenzaMide, 2-[(3-iodo-1H-indazol-6-yl)thio]-N-Methyl-](/CAS/GIF/885126-34-1.gif) |
BenzaMide, 2-[(3-iodo-1H-indazol-6-yl)thio]-N-Methyl- |
885126-34-1 |
C15H12IN3OS |
 |
ForMoterol-IMpurity-B |
1224588-66-2 |
C18H22N2O4 |
![N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/GIF/477600-73-0.gif) |
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
477600-73-0 |
C20H25N5 |
 |
(1R,3aR,7aR)-1-((R)-6-hydroxy-6-Methylheptan-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one |
70550-73-1 |
C18H32O2 |
![3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one](/CAS/GIF/1214741-21-5.gif) |
3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one |
1214741-21-5 |
C12H19NO3 |
![(R)-1-[(3aR,5R,6S,6aR)-5-[[(tert-Butyldiphenylsilyl)oxy]methyl]-2,2-dimethyl-6-(naphthalen-2-ylmethoxy)tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethyl Methanesulfonate](/CAS/20211123/GIF/1174917-65-7.gif) |
(R)-1-[(3aR,5R,6S,6aR)-5-[[(tert-Butyldiphenylsilyl)oxy]methyl]-2,2-dimethyl-6-(naphthalen-2-ylmethoxy)tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethyl Methanesulfonate |
1174917-65-7 |
C38H46O8SSi |
 |
ethyl 7-chloro-8-cyano-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate |
117528-64-0 |
C16H12ClFN2O3 |
 |
(S)-1-(2-(1-aMino-2-Methylpropan-2-ylaMino)acetyl)pyrrolidine-2-carbonitrile dihydrochloride (AMino pyrrolidine) |
739364-93-3 |
C11H22Cl2N4O |
![5-Chloropyrazolo[1,5-a]pyriMidine-3-carbonitrile](/CAS/20150408/GIF/1224288-92-9.gif) |
5-Chloropyrazolo[1,5-a]pyriMidine-3-carbonitrile |
1224288-92-9 |
C7H3ClN4 |
 |
AMinopentaMide Sulfate |
20701-77-3 |
C19H24N2O.H2O4S |
 |
(Ac)Phe-Lys(Alloc)-PABC-PNP |
|
C??H??N?O?? |
 |
2-(DiMethylaMino)acetaldehyde sulfite |
1413945-87-5 |
C4H11NO4S |
 |
Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate |
400827-72-7 |
C3H5N4NaOS |
 |
1,5-Pentanediaminium, N1,N1,N1,N5,N5,N5-hexaethyl-, hydroxide (1:2) |
109591-12-0 |
C17H41N2O+ |
 |
11-Prostaglandin F2a |
|
|
 |
tert-Butyl (1-(2-hydroxyethyl)cyclopropyl)carbamate |
753023-57-3 |
C10H19NO3 |
 |
4-Formyl-2-isopropylthiazole |
133047-46-8 |
C7H9NOS |
![Carbamic acid, N-[(14S,18S)-18,19,20,21-tetrahydro-2-iodo-25,25-dimethyl-15,22-dioxo-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-, 1,1-dimethylethyl ester](/CAS/20240320/GIF/2764998-32-3.gif) |
Carbamic acid, N-[(14S,18S)-18,19,20,21-tetrahydro-2-iodo-25,25-dimethyl-15,22-dioxo-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-, 1,1-dimethylethyl ester |
2764998-32-3 |
C29H36IN5O5S |
![Carbamic acid,N-[(6R,6aR,7R,13S,14R,16R,20R)-5-(acetyloxy)-14-cyano-6,6a,7,13,14,16-hexahydro-9-methoxy-8-(methoxymethoxy)-4,10,23-trimethyl-19-oxo-6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocin-20-yl]-, 1,1-dimethylethyl ester (ACI)](/CAS/20211123/GIF/2081945-64-2.gif) |
Carbamic acid,N-[(6R,6aR,7R,13S,14R,16R,20R)-5-(acetyloxy)-14-cyano-6,6a,7,13,14,16-hexahydro-9-methoxy-8-(methoxymethoxy)-4,10,23-trimethyl-19-oxo-6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocin-20-yl]-, 1,1-dimethylethyl ester (ACI) |
2081945-64-2 |
C38H46N4O11S |
 |
L-Cephalexin |
34632-04-7 |
C16H17N3O4S |
 |
Rimonabant hydrochloride |
158681-13-1 |
C22H21Cl3N4O.ClH |
 |
4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene |
461432-23-5 |
C15H14BrClO |
 |
3-isobutylglutaric anhydride |
185815-59-2 |
C9H14O3 |
 |
7-AMINO-3-(2-FUROYLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID |
80370-59-8 |
C13H12N2O5S2 |